MNK

马林克罗制药
NYSE

实时行情|Nasdaq Last Sale

2.160
-0.090
-4.00%
交易中 12:53 03/31 EDT
开盘
2.250
昨收
2.250
最高
2.380
最低
2.150
成交量
263.04万
成交额
--
52周最高
23.90
52周最低
1.000
市值
1.82亿
市盈率(TTM)
-0.1804
分时
5日
1月
3月
1年
5年

分析师评级

12位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测MNK价格均价为3.230,最高价位6.00,最低价为1.000。

EPS

MNK 新闻

更多
  • Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market
  • Investor's Business Daily · 4小时前
  • ANI Pharma files U.S. application for competitor to Mallinckrodt's Acthar Gel
  • Seeking Alpha - Article · 03/24 15:08
  • Supply chain OK - Mallinckrodt
  • Seeking Alpha - Article · 03/20 19:55
  • Biotech and hospitality stocks among premarket gainers
  • Seeking Alpha - Article · 03/20 13:22

所属板块

制药
-0.15%
制药与医学研究
-0.44%

热门股票

代码
价格
涨跌幅

MNK 简况

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs. Its segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. Its product portfolio includes Acthar, Inomax, Ofirmev, Therakos immunotherapy, Hemostasis products and StrataGraft.
展开

微牛提供Mallinckrodt Plc(NYSE-MNK)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的MNK股票新闻,以帮助您做出投资决策。